Pain Management Therapeutics Market, By Pain Type (Chronic, Acute), By Drug Class (NSAIDS, Anesthetics, Anticonvulsant, Anti-migraine Drugs, Antidepressant Drugs, Opioids, Non-narcotics, Analgesics), By Indication (Arthritic Pain, Neuropathic Pain, Cancer

Pain Management Therapeutics Market, By Pain Type (Chronic, Acute), By Drug Class (NSAIDS, Anesthetics, Anticonvulsant, Anti-migraine Drugs, Antidepressant Drugs, Opioids, Non-narcotics, Analgesics), By Indication (Arthritic Pain, Neuropathic Pain, Cancer Pain, Chronic Pain, Post-operative Pain, Migraine, Fibromyalgia, Bone Fracture, Muscle Sprain/Strain, Acute Appendicitis, Others) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

Pain management is a broad branch of medical science that utilizes an interdisciplinary approach to easing the patient's suffering and enhancing the quality of life of patients with chronic pain. A common aim of pain management is reducing the use of narcotics or pain killers, relaxing the patients' lifestyle and providing education on stress and pain management. The use of pain management treatments in combination with a holistic approach to disease prevention and therapy is now recognized as an effective treatment approach for moderate to severe pain. Chronic pain can result from injury, disease or injury, or be the result of a disease such as cancer or Parkinson's disease.
Market Dynamics:
R&D of new therapeutics is expected to propel growth of the global pain management therapeutics market over the forecast period. For instance, in August 2021, Flexion Therapeutics, Inc. expanded the placebo-controlled trial of FX301, a novel formulation of a locally administered NaV1.7 inhibitor (funapide) which aims to provide at least three to five days of post-operative pain relief while preserving motor function, in patients undergoing bunionectomy.
Moreover, increasing number of pain management clinics is also expected to aid in growth of the market. For instance, in August 2021, QC Kinetix, a regenerative medicine company that offers a non-surgical alternative to pain relief, started a new location Birmingham.
Key features of the study:
This report provides in-depth analysis of the global pain management therapeutics market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2022-2028), considering 2021 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global pain management therapeutics market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include AcelRx Pharmaceuticals, Inc. Averitas Pharma, Inc., AmerisourceBergen, Cardinal Health, McKesson Corporation, Johnson & Johnson, Teva Pharmaceuticals, Abbott Laboratories, Allergan, Inc., Covidien plc, Durect Corporation, Eli Lilly and Company, Endo Health Solutions, Inc., Forest Laboratories, Inc., GlaxoSmithKline plc, Hospira, Inc., Merck & Co., Inc., Mundipharma International Ltd., and Novartis International AG
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global pain management therapeutics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global pain management therapeutics market
Detailed Segmentation:
Global Pain Management Therapeutics Market, By Pain Type:
Chronic
Acute
Global Pain Management Therapeutics Market, By Drug Class:
NSAIDS
Anesthetics
Global Pain Management Therapeutics Market, By Region:
North America
By Pain Type
Chronic
Acute
By Drug Class
NSAIDS
Anesthetics
Anticonvulsant
Anti-migraine Drugs
Antidepressant Drugs
Opioids
Non-narcotics
Analgesics
By Indication
Arthritic Pain
Neuropathic Pain
Cancer Pain
Chronic Pain
Post-operative Pain
Migraine
Fibromyalgia
Bone Fracture
Muscle Sprain/Strain
Acute Appendicitis
Others
By Country
U.S.
Canada
Latin America
By Pain Type
Chronic
Acute
By Drug Class
NSAIDS
Anesthetics
Anticonvulsant
Anti-migraine Drugs
Antidepressant Drugs
Opioids
Non-narcotics
Analgesics
By Indication
Arthritic Pain
Neuropathic Pain
Cancer Pain
Chronic Pain
Post-operative Pain
Migraine
Fibromyalgia
Bone Fracture
Muscle Sprain/Strain
Acute Appendicitis
Others
By Country
Brazil
Mexico
Argentina
Rest of Latin America
Europe
By Pain Type
Chronic
Acute
By Drug Class
NSAIDS
Anesthetics
Anticonvulsant
Anti-migraine Drugs
Antidepressant Drugs
Opioids
Non-narcotics
Analgesics
By Indication
Arthritic Pain
Neuropathic Pain
Cancer Pain
Chronic Pain
Post-operative Pain
Migraine
Fibromyalgia
Bone Fracture
Muscle Sprain/Strain
Acute Appendicitis
Others
By Country
Germany
U.K.
France
Italy
Spain
Russia
Rest of Europe
Asia Pacific
By Pain Type
Chronic
Acute
By Drug Class
NSAIDS
Anesthetics
Anticonvulsant
Anti-migraine Drugs
Antidepressant Drugs
Opioids
Non-narcotics
Analgesics
By Indication
Arthritic Pain
Neuropathic Pain
Cancer Pain
Chronic Pain
Post-operative Pain
Migraine
Fibromyalgia
Bone Fracture
Muscle Sprain/Strain
Acute Appendicitis
Others
By Country
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
Middle East
By Pain Type
Chronic
Acute
By Drug Class
NSAIDS
Anesthetics
Anticonvulsant
Anti-migraine Drugs
Antidepressant Drugs
Opioids
Non-narcotics
Analgesics
By Indication
Arthritic Pain
Neuropathic Pain
Cancer Pain
Chronic Pain
Post-operative Pain
Migraine
Fibromyalgia
Bone Fracture
Muscle Sprain/Strain
Acute Appendicitis
Others
By Country
GCC
Israel
Rest of Middle East
Africa
By Pain Type
Chronic
Acute
By Drug Class
NSAIDS
Anesthetics
Anticonvulsant
Anti-migraine Drugs
Antidepressant Drugs
Opioids
Non-narcotics
Analgesics
By Indication
Arthritic Pain
Neuropathic Pain
Cancer Pain
Chronic Pain
Post-operative Pain
Migraine
Fibromyalgia
Bone Fracture
Muscle Sprain/Strain
Acute Appendicitis
Others
By Country/Region
South Africa
Central Africa
North Africa
Company Profiles
AcelRx Pharmaceuticals, Inc.*
Company Highlights
Products Portfolio
Key Highlights
Financial Performance
Strategies
Averitas Pharma, Inc.
AmerisourceBergen
Cardinal Health
McKesson Corporation
Johnson & Johnson
Teva Pharmaceuticals
Abbott Laboratories
Allergan, Inc
Covidien plc
Durect Corporation
Eli Lilly and Company
Endo Health Solutions, Inc
Forest Laboratories, Inc.
GlaxoSmithKline plc
Hospira, Inc.
Merck & Co., Inc
Mundipharma International Ltd.
Novartis International AG
“*” marked represents similar segmentation in other categories in the respective section.